Trade Jazz Pharmaceuticals plc - JAZZ CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.23 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 109.72 |
| Open | 109.49 |
| 1-Year Change | -16.82% |
| Day's Range | 109.49 - 112.53 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 109.12 | 0.92 | 0.85% | 108.20 | 110.71 | 107.74 |
| Jul 24, 2024 | 108.40 | 0.71 | 0.66% | 107.69 | 109.49 | 107.50 |
| Jul 23, 2024 | 108.36 | 0.08 | 0.07% | 108.28 | 108.75 | 107.48 |
| Jul 22, 2024 | 109.58 | 2.03 | 1.89% | 107.55 | 109.78 | 106.85 |
| Jul 19, 2024 | 108.85 | 0.60 | 0.55% | 108.25 | 109.30 | 107.54 |
| Jul 18, 2024 | 108.45 | 1.00 | 0.93% | 107.45 | 110.05 | 106.35 |
| Jul 17, 2024 | 107.93 | 2.72 | 2.59% | 105.21 | 108.29 | 105.21 |
| Jul 16, 2024 | 105.99 | 3.17 | 3.08% | 102.82 | 105.99 | 102.71 |
| Jul 15, 2024 | 103.17 | -0.78 | -0.75% | 103.95 | 105.20 | 102.87 |
| Jul 12, 2024 | 105.45 | 0.29 | 0.28% | 105.16 | 107.06 | 104.95 |
| Jul 11, 2024 | 106.00 | 4.00 | 3.92% | 102.00 | 106.24 | 101.72 |
| Jul 10, 2024 | 102.10 | 2.07 | 2.07% | 100.03 | 102.20 | 98.70 |
| Jul 9, 2024 | 100.49 | 0.47 | 0.47% | 100.02 | 101.19 | 99.54 |
| Jul 8, 2024 | 100.61 | -0.84 | -0.83% | 101.45 | 102.05 | 100.21 |
| Jul 5, 2024 | 100.87 | -2.08 | -2.02% | 102.95 | 102.95 | 100.17 |
| Jul 3, 2024 | 103.12 | -1.15 | -1.10% | 104.27 | 105.07 | 102.45 |
| Jul 2, 2024 | 104.95 | -1.03 | -0.97% | 105.98 | 106.21 | 104.26 |
| Jul 1, 2024 | 106.42 | 0.27 | 0.25% | 106.15 | 108.05 | 106.05 |
| Jun 28, 2024 | 106.64 | 0.00 | 0.00% | 106.64 | 108.37 | 106.10 |
| Jun 27, 2024 | 106.99 | 0.88 | 0.83% | 106.11 | 107.38 | 105.41 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Jazz Pharma Company profile
About Jazz Pharmaceuticals PLC
Jazz Pharmaceuticals Public Limited Company is a biopharmaceutical company. The Company is focused on developing and commercializing products that address unmet medical needs. The Company has a diverse portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology. The Company's lead marketed products include Xyrem (sodium oxybate oral solution) for the treatment of both cataplexy and excessive daytime sleepiness in patients with narcolepsy; Erwinaze for the treatment of acute lymphoblastic leukemia (ALL), and Defitelio (defibrotide) for the treatment of severe hepatic veno-occlusive disease (VOD). The Company also commercializes Prialt, an intrathecally administered infusion of ziconotide, approved by the FDA for the management of severe chronic pain in patients for whom intrathecal therapy is warranted, and who are intolerant of or refractory to other treatment, such as systemic analgesics, adjunctive therapies or intrathecal morphine.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Jazz Pharmaceuticals PLC revenues increased 31% to $3.09B. Net loss totaled $329.7M vs. income of $238.6M. Revenues reflect Sunosi segment increase from $28.3M to $2.34B, Zepzelca segment increase from $90.4M to $246.8M, United States segment increase of 32% to $2.82B, Europe segment increase of 31% to $230.2M. Net loss reflects Selling.
Equity composition
Common Stock $.0001 Par, 4/11, 150M auth., 40,741,809 issd. Insiders & stakeholders own 2.30%. IPO 6/1/07, 6M shares @ $18 per share by Morgan Stanley & Co. Incorporated, Lehman Brothers Inc. 5/07 Reverse stock split 1 for 11.06701. PO: 7/08, 3.8M shares.
| Industry: | Pharmaceuticals (NEC) |
Fifth Fl
Waterloo Exchange
DUBLIN
DUBLIN 4
IE
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com